PTHS · ISSUER CIK 1919246
Pelthos Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Pelthos Therapeutics Inc. insiders reported $0.00 of open-market purchases and $45K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$45KInsider selling
−$45KNet open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202617:54 | Oct 2, 2026 | PTHS | Director | S · Sell10b5-1 | $21.17 | −797 | 23,087 | -3% | −$17K | ||
| Oct 6, 202617:53 | Oct 2, 2026 | PTHS | Director | S · Sell10b5-1 | $20.72 | −558 | 80,484 | -1% | −$12K | ||
| Oct 6, 202617:53 | Oct 2, 2026 | PTHS | Director | S · Sell10b5-1 | $21.00 | −786 | 13,578 | -5% | −$17K |